88IV - PR Newswire Asia's news


ImmunoForge to Conduct Strategic Partnering at Bio-Europe Spring 2026 Conducting global licensing partnering of LMT15, a proprietary BBB Shuttle platform Also discussing global out-licensing of Phase 2 stage new drugs PF1801 and PF1804 SEOUL, South Korea , ... 2026-03-12T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub Strategic investment reinforces Europe as a core pillar of GenScript's global R&D and production network, following recent U.S. facility expansion. ... 2026-03-12T Biotechnology Computer/Electronics Health Care/Hospital
Precision for Medicine Continues Asia-Pacific Expansion with Opening of Japan Office New Tokyo office strengthens local partnerships, regulatory alignment and global integrations in the world's third largest pharmaceutical market ... 2026-03-12T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Locus Cell, Taiwan-Based Cell and Gene Therapy CDMO, Signs MoU with Charles River at APAC Biomanufacturing Leadership Summit SINGAPORE , March 12, 2026 /PRNewswire/ -- Locus Cell Co., Ltd. ("Locus Cell"), a Taiwan-based cell and gene therapy (CGT) Contract Development and Manufacturing Organization (CDMO), and Charles ... 2026-03-12T Biotechnology Health Care/Hospital
LabConnect Expands Global Central Laboratory Infrastructure with Wuxi, China Facility WUXI, China , March 12, 2026 /PRNewswire/ -- LabConnect, a leading provider of technology-driven central laboratory services and functional service provider solutions for clinical trials, today announced ... 2026-03-12T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
/C O R R E C T I O N -- Gesynta Pharma/ In the news release, First patient dosed in Gesynta Pharma's endometriosis trial of vipoglanstat, issued 11-Mar-2026 by Gesynta Pharma over PR Newswire, the source was erroneously mentioned as Getinge ... 2026-03-11T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
GC Biopharma Publishes a Comprehensive Review Paper Summarizing 30 Years of Accumulated Data on Its Proprietary Varicella Vaccine Strain, 'MAV/06' Demonstrates effectiveness comparable to the global standard Oka strain vaccine YONGIN, South Korea , March 11, 2026 /PRNewswire/ -- GC Biopharma(006280.KS), a leading provider of biopharmaceutical ... 2026-03-11T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Alphamab Oncology Appoints Dr. Hongwei Wang as Chief Technology Officer SUZHOU, China , March 11, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced the appointment of Dr. Hongwei Wang as Chief Technology Officer (CTO). Dr. Wang will be responsible for ... 2026-03-11T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Bota Launches SAION AI -- Physical AI Platform for Biomanufacturing SAN FRANCISCO and HANGZHOU, China , March 11, 2026 /PRNewswire/ -- As AI reshapes the digital world through cognitive and generative capabilities, a new frontier emerges: Physical AI — an intelligent ... 2026-03-11T Biotechnology Computer/Electronics
Tsingke Biotech and iGeneTech Forge Strategic Partnership to Lead Synthetic Biology Advancements BEIJING , March 10, 2026 /PRNewswire/ -- Beijing Tsingke Biotech Co., Ltd. (" Tsingke Biotech ") and iGeneTech Bioscience Co., Ltd. ("iGeneTech") have announced a strategic ... 2026-03-10T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology